The company unveiled The Vest APX at the North American Cystic Fibrosis Conference in Boston. Its system supports daily therapy for adults and children with certain chronic lung conditions and retained secretions. The Vest APX features the same airflow technology as its previous iteration with enhanced comfort and additional patient-centered features. It received FDA 510(k) clearance earlier this year.

Features include a streamlined, lightweight garment that keeps the abdomen free, plus a wicking fabric to keep patient’s cool. Its Velcro brand closure helps provide an optimal fit. Patients can also choose from an expanded selection of garment colors and designs.